BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25516257)

  • 1. Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study.
    Schock H; Fortner RT; Surcel HM; Grankvist K; Pukkala E; Lehtinen M; Lundin E
    Int J Cancer; 2015 Jul; 137(2):439-47. PubMed ID: 25516257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.
    Ose J; Schock H; Poole EM; Lehtinen M; Visvanathan K; Helzlsouer K; Buring JE; Lee IM; Tjønneland A; Boutron-Ruault MC; Trichopoulou A; Mattiello A; Onland-Moret NC; Weiderpass E; Sánchez MJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
    Cancer Causes Control; 2017 May; 28(5):429-435. PubMed ID: 28205047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.
    Schock H; Surcel HM; Zeleniuch-Jacquotte A; Grankvist K; Lakso HÅ; Fortner RT; Kaaks R; Pukkala E; Lehtinen M; Toniolo P; Lundin E
    Endocr Relat Cancer; 2014; 21(6):831-44. PubMed ID: 25270324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort.
    Ose J; Fortner RT; Schock H; Peeters PH; Onland-Moret NC; Bueno-de-Mesquita HB; Weiderpass E; Gram IT; Overvad K; Tjonneland A; Dossus L; Fournier A; Baglietto L; Trichopoulou A; Benetou V; Trichopoulos D; Boeing H; Masala G; Krogh V; Matiello A; Tumino R; Popovic M; Obón-Santacana M; Larrañaga N; Ardanaz E; Sánchez MJ; Menéndez V; Chirlaque MD; Travis RC; Khaw KT; Brändstedt J; Idahl A; Lundin E; Rinaldi S; Kuhn E; Romieu I; Gunter MJ; Merritt MA; Riboli E; Kaaks R
    Br J Cancer; 2015 Jan; 112(1):162-6. PubMed ID: 25349976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study.
    Toriola AT; Surcel HM; Lundin E; Schock H; Grankvist K; Pukkala E; Chen T; Toniolo P; Lehtinen M; Zeleniuch-Jacquotte A; Lukanova A
    Cancer Causes Control; 2011 Nov; 22(11):1607-11. PubMed ID: 21833488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower levels of placental growth hormone in early pregnancy in women with type 1 diabetes and large for gestational age infants.
    Ringholm L; Juul A; Pedersen-Bjergaard U; Thorsteinsson B; Damm P; Mathiesen ER
    Growth Horm IGF Res; 2015 Dec; 25(6):312-5. PubMed ID: 26589570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Peeters PH; Lukanova A; Allen N; Berrino F; Key T; Dossus L; Rinaldi S; van Gils CH; Bueno-de-Mesquita HB; Boeing H; Schulz M; Chang-Claude J; Linseisen J; Panico S; Sacerdote C; Palli D; Tumino R; Trichopoulou A; Trichopolos D; Bamia C; Larranaga N; Ardanaz E; Pera G; Quirós JR; Martínez-García C; Navarro C; Bingham SA; Khaw KT; Clavel F; Tjonneland A; Olsen A; Overvad K; Tetsche MS; Lund E; Lundin E; Berglund G; Riboli E; Kaaks R
    Endocr Relat Cancer; 2007 Mar; 14(1):81-90. PubMed ID: 17395977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Mullerian hormone and risk of invasive serous ovarian cancer.
    Schock H; Lundin E; Vääräsmäki M; Grankvist K; Fry A; Dorgan JF; Pukkala E; Lehtinen M; Surcel HM; Lukanova A
    Cancer Causes Control; 2014 May; 25(5):583-9. PubMed ID: 24562905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European Consortium.
    Rohr I; Zeillinger R; Heinrich M; Concin N; Vergote I; Nassir M; Mahner S; VAN Nieuwenhuysen E; Trillsch F; Cacsire-Tong D; Chekerov R; Sehouli J; Braicu EI
    Anticancer Res; 2016 Mar; 36(3):1015-22. PubMed ID: 26976992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
    Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
    Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I in pregnancy and maternal risk of breast cancer.
    Lukanova A; Toniolo P; Zeleniuch-Jacquotte A; Grankvist K; Wulff M; Arslan AA; Afanasyeva Y; Johansson R; Lenner P; Hallmans G; Wadell G; Lundin E
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2489-93. PubMed ID: 17132766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth.
    Chellakooty M; Vangsgaard K; Larsen T; Scheike T; Falck-Larsen J; Legarth J; Andersson AM; Main KM; Skakkebaek NE; Juul A
    J Clin Endocrinol Metab; 2004 Jan; 89(1):384-91. PubMed ID: 14715876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.
    Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R
    Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.
    Pylväs-Eerola M; Karihtala P; Puistola U
    BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women.
    Sköld C; Bjørge T; Ekbom A; Engeland A; Gissler M; Grotmol T; Madanat-Harjuoja L; Gulbech Ording A; Stephansson O; Trabert B; Tretli S; Troisi R; Sørensen HT; Glimelius I
    Int J Cancer; 2018 Oct; 143(8):1858-1867. PubMed ID: 29737528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.
    Cramer DW; Vitonis AF; Terry KL; Welch WR; Titus LJ
    Epidemiology; 2016 May; 27(3):334-46. PubMed ID: 26689397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics of borderline ovarian tumors and stage I epithelial ovarian cancer: an analysis of 143 cases].
    Zhao Y; Wang Y; Shen Dh; Song Rn; Xu Q; Li Y; Cui H; Tang J; Wei Lh
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):123-8. PubMed ID: 21321635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of maternal insulin-like growth factor I by placental growth hormone in pregnancy. Possible action of maternal IGF-I on fetal growth.
    Caufriez A; Frankenne F; Hennen G; Copinschi G
    Horm Res; 1994; 42(1-2):62-5. PubMed ID: 7959636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.